Thus, we hypothesized that increasing phosphatidylserine (PS) externalization to the outer cell surface of endothelial and tumor cells induced by pro-apoptotic activity of doxorubicin can lead to a better procoagulatory milieu and consecutively to a more efficient FX activation by tTF-NGR. This evidence concerns the gene F10 and neoplasm.